Trial Profile
A Single Center Study to Evaluate the Effectiveness and Safety of Add on Enstilar in Patients Using OTEZLA for Moderate to Severe Plaque Psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Apr 2024
Price :
$35
*
At a glance
- Drugs Apremilast (Primary) ; Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 18 Apr 2024 Status changed from recruiting to completed.
- 27 Aug 2018 Status changed from not yet recruiting to recruiting.
- 18 Jul 2018 New trial record